Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis

E-ISSN： 1875-6360|7|4|306-312

ISSN： 1573-3971

Source： Current Rheumatology Reviews, Vol.7, Iss.4, 2011-11, pp. : 306-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The JAK inhibitor tofacitinib for active rheumatoid arthritis: results from Phase III trials

By Salgado Eva Gómez-Reino Juan J

International Journal of Clinical Rheumatology, Vol. 8, Iss. 3, 2013-06 ,pp. : 315-326

Future Medicine

Access to resources Recommend Favorite

Hyaluronan inhibits p38 mitogen-activated protein kinase via the receptors in rheumatoid arthritis chondrocytes stimulated with fibronectin fragment

By Yasuda Tadashi

Clinical Rheumatology, Vol. 29, Iss. 11, 2010-11 ,pp. : 1259-1267

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of TNFα-Inhibitors on Cardiovascular Events in Patients with Rheumatoid Arthritis: An Updated Systematic Review of the Literature

Current Rheumatology Reviews, Vol. 12, Iss. 3, 2016-12 ,pp. : 208-222

Bentham Science Publishers

Access to resources Recommend Favorite

Immunosenescence, autoimmunity, and rheumatoid arthritis

By Weyand C.M. Fulbright J.W. Goronzy J.J.

Experimental Gerontology, Vol. 38, Iss. 8, 2003-08 ,pp. : 833-841

Elsevier

Access to resources Recommend Favorite

Rheumatoid arthritis in the elderly

By Mavragani C.P. Moutsopoulos H.M.

Experimental Gerontology, Vol. 34, Iss. 3, 1999-06 ,pp. : 463-471

Elsevier

Access to resources Recommend Favorite